CGM Academy for Youth With Type 1 Diabetes
ConditionType1 Diabetes
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age8-18
SponsorChildren's Hospital Los Angeles
About this trial
The goal of this randomized clinical trial is to compare the effects of a virtual education curriculum in blood glucose variation of youth with type 1 diabetes wearing continuous glucose monitoring (CGM) device. The main questions the study aims to answer are:
* Do participants undertaking the proposed curriculum present improved glucose variation than participants of standard education? * Explore relationships between participant's glycemic outcomes with diabetes distress, diabetes family responsibilities, and number of hours of diabetes education.
Participants in the intervention group will:
* receive an interactive workbook with problem-based learning scenarios and video links about CGM and glucose management strategies. * participate in four in-depth online group sessions with diabetes care and education specialists * complete questionnaires three times: at the time of study enrollment, week 4 and 6 months.
Participants in the comparison group will:
* receive standard education provided to all patients at CHLA * complete questionnaires three times: at the time of study enrollment, week 4 and 6 months.
Eligibility criteria
Qualifiers
Current age of 8-18 years, age group eligible for CGM therapy with Dexcom G6 and G7
T1D duration ≥6 months, as insulin adjustments during honeymoon stage differs from establishedT1D
Able to speak, read, and write English or Spanish
Smartphone compatible with Dexcom G6 and G7application
Disqualifiers
None
Trial design
Treatments tested in this trial
- CGM Academy
Treatment groups
90 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov